Downregulation of Opa1 and Marf does affect type II NB numbers but affect differentiated cells in lineage. by Dnyanesh Dubal (12085942)

Subjects:

Analysis of change in mature INPs, GMCs and neurons in the type II NB lineage on depletion of mitochondrial morphology proteins. by Dnyanesh Dubal (12085942)

Subjects:

Fibrosis markers. by Dwight D. Harris (14484648)

Flowchart of the steps involved in the high-throughput exoproteome screening assay (HESA). by Marion Schoof (11999106)

(A) Digital designing of premolar to decrease 1 mm of root surface, (B) 3D printed tooth compared to artificial tooth of model. by Samar S. Alaghbari (21863491)

Elementary Steps in Olefin Metathesis: Nickelacyclobutanes via Cycloaddition to Nickel Carbenes by Samantha K. Cormier (16872384)

“…We describe Ni(PP)(=CPh₂) complexes that provide this missing evidence. …”

Immunoblotting for TGF-beta, alpha-actinin, MMP-13, and mTOR. by Dwight D. Harris (14484648)

Immunoblotting for JAK, STAT, and SMAD. by Dwight D. Harris (14484648)

The oxygen level (kPa) for 50 and 100% habitat loss for each species and season under a doubling of atmospheric CO₂. by Emily Slesinger (6837740)

Immunoblotting for insulin sensitivity markers. by Dwight D. Harris (14484648)

Immunoblotting FOXO1 and insulin receptors. by Dwight D. Harris (14484648)

Delphinidin alters VEGF-A splicing to increase VEGF-A₁₆₅b and decrease total VEGF-A expression. by Megan Stevens (3964886)

“…<p><b>A)</b> Treatment of podocytes with delphinidin chloride (10 μg/ml) under normal glucose (NG; 5 mM glucose + 25 mM mannitol) and high glucose (HG; 30 mM glucose, 1 ng/ml TNFα, 1 ng/ml IL-6, and 100 nM insulin) for 48 hrs increased the protein expression of VEGF-A₁₆₅b relative to total VEGF-A₁₆₅ (quantified in <b>B</b>; *p<0.05 vs NG, †p<0.05 vs HG; n = 3 biological repeats; One-way ANOVA with Bonferroni post-hoc test for comparison between pairs; <b>A</b>—the same blot was first probed with VEGF-A₁₆₅b before stripping and reprobing with panVEGF-A). …”

Table 1_Atractylenolide-I restore intestinal barrier function by targeting the S100A9/AMPK/mTOR signaling pathway.xlsx by Chen Chen (6544)

“…Mechanistically, recombinant human S100A9 protein was found to induce a decrease in intracellular Ca²⁺ concentration, while AT-1 regulated the expression of tight junction proteins via modulation of the AMPK/mTOR signaling pathway. …”

Image 2_Atractylenolide-I restore intestinal barrier function by targeting the S100A9/AMPK/mTOR signaling pathway.tif by Chen Chen (6544)

“…Mechanistically, recombinant human S100A9 protein was found to induce a decrease in intracellular Ca²⁺ concentration, while AT-1 regulated the expression of tight junction proteins via modulation of the AMPK/mTOR signaling pathway. …”

Image 1_Atractylenolide-I restore intestinal barrier function by targeting the S100A9/AMPK/mTOR signaling pathway.tif by Chen Chen (6544)

“…Mechanistically, recombinant human S100A9 protein was found to induce a decrease in intracellular Ca²⁺ concentration, while AT-1 regulated the expression of tight junction proteins via modulation of the AMPK/mTOR signaling pathway. …”

Decreased production of IL-12p70 and IL-23 in response to LPS+R848 stimulation in frail old individuals. by Nathalie Compté (418458)

Plot showing stages of IPIs recorded from the completed drinking bouts by all bats. by Laura N. Kloepper (8173881)

Diabetic wounds show increased amounts of vessel leakage and decreased pericyte coverage. by Uzoagu A. Okonkwo (8754933)

TrpA1 activation fails to enhance poly-UB aggregate accumulation conferred by neuronal <i>atl</i> knockdown. by Saurabh Srivastav (9585817)

ApoA-I inhibits leukocyte adhesion to endothelial cells <i>in vivo</i>. by Scott J. Cameron (838315)

“…(B) ApoA-I knockout mice (apoA-I ^-/-) have low plasma HDL concentration compared to WT mice and show increased adhesion of leukocytes to the vascular endothelium <i>in vivo</i> (decreased rolling velocity) compared to WT mice or apoA-I ^-/- mice injected with apo-AI (0.5mg, intraperitoneal) 24 hours before. …”